research ethics
DESCRIPTION
Research Ethics. Dr Mary Tully School of Pharmacy and Pharmaceutical Sciences & Chair of Salford & Trafford NHS Ethics Committee (2007-2009). Presentation. Remit of NHS ethics committees Imminent changes Ethics application process within NHS - PowerPoint PPT PresentationTRANSCRIPT
Combining the strengths of UMIST and
The Victoria University of Manchester
Research Ethics
Dr Mary TullySchool of Pharmacy and Pharmaceutical Sciences &
Chair of Salford & Trafford NHS Ethics Committee (2007-2009)
Presentation
• Remit of NHS ethics committees
• Imminent changes
• Ethics application process within NHS
• Information required for ethical consideration of research
Key Principles of Ethical Research
• Well-being of subject takes precedence over interests of science and society
• It is the duty of the physician to protect the life, health, privacy and dignity of the human subject
• Conform to generally accepted scientific principles by appropriately qualified persons
• Assessment of predictable risks and burdens in comparison with foreseeable benefits – the former should outweigh the latter
• Subjects must be volunteers and informed participants
NHS Research Ethics Committees Organisation
• NHS ethics committees were previously independent bodies
• Now controlled by a single body (NRES) with a single set of Standard Operating Procedures
• Operate under the Governance Arrangements for Research Ethics Committees (GAfREC)
• Use a single form for all ethics committees
• Approval from a single ethics committee is acceptable to all other committees
Currently - Studies Needing NHS REC Approval
• Those that involve:
– patients and users of the NHS
– relatives or carers of patients and users of the NHS
– access to data, organs or other bodily material of past and present NHS patients
– foetal material and IVF involving NHS patients
– the recently dead in NHS premises
– the use of, or potential access to, NHS premises or facilities
– NHS staff - recruited by virtue of professional role
GAFREC version 2 – out for consultation
• 2.3.2 Those that involve:
– past or present users of NHS & adult social services
– relatives or carers of past or present users of these services;
– collection of tissue/information from users of these services;
– use of previously collected tissue or information from which individual past or present users of these services could be identified
2.3.5 – Legislation requires REC review of research involving:
• (a) people who lack (or lose) the capacity to give informed consent to take part (or to keep taking part) in the research;
• (b) processing of confidential patient information without consent where this would otherwise breach confidentiality;
• (c) material consisting of or including human cells (unless anonymous & obtained with consent);
• (d) people who are cared for in the private and voluntary sector, e.g. in nursing homes or residential care homes;
• (e) exposure to ionising radiation;
• (f) medical devices that are not CE-marked (i.e. not compliant with European Directives) or CE-marked medical devices that have been modified or are being used for a new purpose;
• (g) investigational medicinal products;
• (h) practising midwives conducting a clinical trial; or
• (i) protected information from the Human Fertilisation and Embryology Authority register.
“No material ethical issues”
• Proportionate ethical review pilot in London from 1st September 2009
– Research using data or tissue that is anonymous TO THE RESEARCHER
– Research using existing tissue samples already taken with consent for research
– Research using “extra tissue” (e.g. further blood taken at time of routine sampling or tissue taken at “clinically directed” operation)
– Questionnaire research that does NOT include highly sensitive areas or where accidental disclosure would NOT have serious consequences
– Research interview / focus group that does NOT include highly sensitive areas or where accidental disclosure would NOT have serious consequences
– Research surveying the safety or efficacy of established non drug treatments, involving limited intervention and NO change to the patients’ treatment
http://www.nres.npsa.nhs.uk/applications/guidance/#appguide
Complete ethics applicationform
Phone to book in & get number
Submit completed form and supporting documentation
Application reviewed by main REC
Favourable Unfavourable
Sponsor ensures scientific review
Submit study to R&D office at each site
AppealTrust approval at each site
Modifications & reapply
From April 2009
Provisional
Modifications
www.myresearchproject.org.uk/
Membership of committees
• Salford & Trafford as an example
– Pharmacist
– Paediatric oncologist
– GP
– Nurse x 3
– Anaesthetist
– Medical statistician
– Clinical psychologist
– Community health care worker
– Retired physicist
– Engineer
– Professor in Cell Biology
– Builder
How to really annoy an ethics committee!
• Assume we are all experts in your area
• Assume that we are all stupid
• Assume that the research participant is an expert in your area
• Don’t answer the questions on the form
• Don’t bother proofreading
• Be really careless
Lay language
• “It is crucial that your answers to these questions are written in a way that will be understood by lay members of the Committee.
• Lay members may not have worked in the NHS or have any experience of clinical research.
• It is not acceptable to cut and paste from the protocol.
• You could be asked to rewrite your answers if you do not adhere to this guidance.”
• “The principal objective is to study the frequency of different allelic forms of immune response genes that may contribute towards the pathogenesis of various rheumatic and/or autoimmune diseases. Specific genetic polymorphisms may contribute to either the development of disease (susceptibility), the development of specific disease features (e.g. pattern of joint involvement and extra-articular manifestations) or alternatively may contribute to disease severity.”
What does committee look for?
• Scientific design & conduct of study
• Recruitment of research participants
• Consent
• Care & protection of research participants
• Protection of participants’ confidentiality
• Other considerations
• Will this research answer the question the researcher has posed?
• Does the research involved a placebo? How ethical is this? Have subjects being told?
• What are the criteria for prematurely withdrawing research participants?
• Etc …
Scientific design & conduct of study e.g.
• How will initial contact and recruitment be conducted?
• What are the inclusion and exclusion criteria for research participants, and are they justified?
• Etc …
Recruitment of research participants e.g.
Consent e.g.
• How will consent to be obtained?
• Is the information given appropriate, complete and understandable?
• What is the justification for including individuals who cannot consent?
• Etc …
Subject Information Sheets e.g.
• Question and answer format – standard NRES format
• Plain, concise English
• Should be true and not withhold information
• Risks and benefits outlined - of both arms in a controlled study
• Etc …
Care and protection of research participants e.g.
• Are there any plans to withhold or withdraw standard therapies?
• Will the research participants received any compensation/reward for their participation?
• Etc …
Protection of participants’ confidentiality e.g.
• Who will have access to the personal data of the research participants?
• To what extent will information about participants be anonymous?
• Will data be sent outside the EU?
• Etc …
Conclusions
• Changes are coming to the system in next 6 months
– New GAFREC
– Proportionate review system
• Take advice from as many people as you can
• Take advice from ethics committee members or coordinator
• Getting ethics approval may not be as awful as you think!